These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37076803)

  • 1. Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.
    Hu C; Iyer RK; Juran BD; McCauley BM; Atkinson EJ; Eaton JE; Ali AH; Lazaridis KN
    BMC Gastroenterol; 2023 Apr; 23(1):129. PubMed ID: 37076803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
    Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.
    Tabibian JH; Enders F; Imam MH; Kolar G; Lindor KD; Talwalkar JA
    Ann Hepatol; 2014; 13(3):384-9. PubMed ID: 24756015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
    Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
    Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation.
    Mousa OY; Juran BD; McCauley BM; Vesterhus MN; Folseraas T; Turgeon CT; Ali AH; Schlicht EM; Atkinson EJ; Hu C; Harnois D; Carey EJ; Gossard AA; Oglesbee D; Eaton JE; LaRusso NF; Gores GJ; Karlsen TH; Lazaridis KN
    Hepatology; 2021 Jul; 74(1):281-295. PubMed ID: 33226645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
    Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
    Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
    Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
    Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.